<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="review-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">mvjr</journal-id><journal-title-group><journal-title xml:lang="ru">Медицинский вестник Юга России</journal-title><trans-title-group xml:lang="en"><trans-title>Medical Herald of the South of Russia</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2219-8075</issn><issn pub-type="epub">2618-7876</issn><publisher><publisher-name>The Rostov State Medical University</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.21886/2219-8075-2024-15-1-82-93</article-id><article-id custom-type="elpub" pub-id-type="custom">mvjr-1892</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>АКУШЕРСТВО И ГИНЕКОЛОГИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>OBSTETRICS AND GYNECOLOGY</subject></subj-group></article-categories><title-group><article-title>«Белые пятна» в диагностическом поиске причин невынашивания беременности</article-title><trans-title-group xml:lang="en"><trans-title>“White spots” in the diagnostic search for the causes of recurrent miscarriage</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-2602-1486</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Лебеденко</surname><given-names>Е. Ю.</given-names></name><name name-style="western" xml:lang="en"><surname>Lebedenko</surname><given-names>E. Yu.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Лебеденко Елизавета Юрьевна, д.м.н., доцент, заведующая кафедрой акушерства и гинекологии №3</p><p>Ростов-на-Дону</p></bio><bio xml:lang="en"><p>Elizaveta Yu. Lebedenko, Dr. Sc. (Med.), associate Professor, Head of the Department of Obstetrics and Gynecology No. 3</p><p>Rostov-on-Don</p></bio><email xlink:type="simple">lebedenko08@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-8282-2248</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Михельсон</surname><given-names>Ар. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Mikhelson</surname><given-names>Ar. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Михельсон Артур Александрович, к.м.н., доцент кафедры акушерства и гинекологии №3</p><p>Ростов-на-Дону</p></bio><bio xml:lang="en"><p>Artur A. Mikhelson, C. Sc. (Med.), associate professor of the Department of Obstetrics and Gynecology No. 3</p><p>Rostov-on-Don</p></bio><email xlink:type="simple">artur.mikhelson@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-5053-5941</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Михельсон</surname><given-names>А. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Mikhelson</surname><given-names>A. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Михельсон Александр Александрович, к.м.н., доцент кафедры акушерства и гинекологии №3</p><p>Ростов-на-Дону</p></bio><bio xml:lang="en"><p>Aleksandr A. Mikhelson, C. Sc. (Med.), associate professor of the Department of Obstetrics and Gynecology No. 3</p><p>Rostov-on-Don</p></bio><email xlink:type="simple">michelson_aa@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0003-9959-846X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Змиенко</surname><given-names>В. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Zmienko</surname><given-names>V. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Змиенко Вера Андреевна, аспирант кафедры акушерства и гинекологии №3</p><p>Ростов-на-Дону</p></bio><bio xml:lang="en"><p>Vera A. Zmienko, postgraduate student of the Department of Obstetrics and Gynecology No. 3</p><p>Rostov-on-Don</p></bio><email xlink:type="simple">vesazonova@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0009-3668-3417</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Сагамонов</surname><given-names>А. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Sagamonov</surname><given-names>A. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Сагамонов Артур Сергеевич, ординатор кафедры акушерства и гинекологии №3</p><p>Ростов-на-Дону</p></bio><bio xml:lang="en"><p>Artur S. Sagamonov, resident doctor of the Department of Obstetrics and Gynecology No. 3</p><p>Rostov-on-Don</p></bio><email xlink:type="simple">a.sagamonov@gmail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0000-6071-4396</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Кормануков</surname><given-names>Х. Ю.</given-names></name><name name-style="western" xml:lang="en"><surname>Kormanukov</surname><given-names>H. Yu.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Кормануков Хачерес Юрьевич, студент 5 курса лечебно-профилактического факультета</p><p>Ростов-на-Дону</p></bio><bio xml:lang="en"><p>Hacheres Yu. Kormanukov, 5th year student of the Faculty of Treatment and Prevention</p><p>Rostov-on-Don</p></bio><email xlink:type="simple">po4tayashik715@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Ростовский государственный медицинский университет</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Rostov State Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2024</year></pub-date><pub-date pub-type="epub"><day>13</day><month>03</month><year>2024</year></pub-date><volume>15</volume><issue>1</issue><fpage>82</fpage><lpage>93</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Лебеденко Е.Ю., Михельсон А.А., Михельсон А.А., Змиенко В.А., Сагамонов А.С., Кормануков Х.Ю., 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder xml:lang="ru">Лебеденко Е.Ю., Михельсон А.А., Михельсон А.А., Змиенко В.А., Сагамонов А.С., Кормануков Х.Ю.</copyright-holder><copyright-holder xml:lang="en">Lebedenko E.Y., Mikhelson A.A., Mikhelson A.A., Zmienko V.A., Sagamonov A.S., Kormanukov H.Y.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.medicalherald.ru/jour/article/view/1892">https://www.medicalherald.ru/jour/article/view/1892</self-uri><abstract><p>Невынашивание беременности — не только медицинская, но и социальная проблема, носящая мультифакториальный характер, которая остается нерешаемой несмотря на постоянный поиск и применение новых диагностических и терапевтических стратегий. В представленном обзоре рассматриваются данные литературы о доказательных аспектах причин невынашивания беременности, а также методах, использование которых остается дискутабельным. Особое внимание уделяется иммунологическим основам формирования нормальной беременности, нарушение которых создает предпосылки для привычного выкидыша. Также в работе проанализированы современные данные о роли рецептивности эндометрия и вклада мужского фактора в проблему невынашивания, представлены перспективы дальнейших исследований по проблеме рецидивирующих репродуктивных потерь ранних сроков.</p></abstract><trans-abstract xml:lang="en"><p>Recurrent pregnancy loss is not only a medical, but also a social problem of a multifactorial nature. This problem remains unsolvable despite the constant search and application of new diagnostic and therapeutic strategies. The presented review examines the literature data on evidence-based methods for diagnosing the causes of miscarriage, as well as methods whose use remains controversial. Special attention is paid to the immunological foundations of a normal pregnancy formation, the violation of which creates the prerequisites for a recurrent miscarriage. The paper also analyzes current data on the role of endometrial receptivity and the contribution of the male factor to the problem of miscarriage, and presents prospects for further research on the problem of recurrent pregnancy loss.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>привычный выкидыш</kwd><kwd>невынашивание беременности</kwd><kwd>рецептивность эндометрия</kwd><kwd>иммунологические механизмы</kwd><kwd>мужской фактор невынашивания</kwd></kwd-group><kwd-group xml:lang="en"><kwd>recurrent miscarriage</kwd><kwd>recurrent pregnancy loss</kwd><kwd>endometrial receptivity</kwd><kwd>immunological mechanisms</kwd><kwd>male factor of recurrent miscarriage</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">ESHRE «Recurrent pregnancy loss». 2019.</mixed-citation><mixed-citation xml:lang="en">ESHRE «Recurrent pregnancy loss». 2019.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Practice Committee of the American Society for Reproductive Medicine. Evaluation and treatment of recurrent pregnancy loss: a committee opinion. Fertil Steril. 2012;98(5):1103-1111. https://doi.org/10.1016/j.fertnstert.2012.06.048</mixed-citation><mixed-citation xml:lang="en">Practice Committee of the American Society for Reproductive Medicine. Evaluation and treatment of recurrent pregnancy loss: a committee opinion. Fertil Steril. 2012;98(5):1103-1111. https://doi.org/10.1016/j.fertnstert.2012.06.048</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">The investigation and treatment of couples with recurrent first-trimester and second-trimester miscarriage. RCOG Green-top guideline. 2011;(17):1-18.</mixed-citation><mixed-citation xml:lang="en">The investigation and treatment of couples with recurrent first-trimester and second-trimester miscarriage. RCOG Green-top guideline. 2011;(17):1-18.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Российское общество акушеров-гинекологов. Клинические рекомендации «Привычный выкидыш». М.; 2022.</mixed-citation><mixed-citation xml:lang="en">Российское общество акушеров-гинекологов. Клинические рекомендации «Привычный выкидыш». М.; 2022.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Russian society of obstetricians and gynaecologists. Clinical guideline «Recurrent pregnancy loss». Мoscow; 2022. (In Russ.)</mixed-citation><mixed-citation xml:lang="en">Russian society of obstetricians and gynaecologists. Clinical guideline «Recurrent pregnancy loss». Мoscow; 2022. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">van Dijk MM, Kolte AM, Limpens J, Kirk E, Quenby S, et al. Recurrent pregnancy loss: diagnostic workup after two or three pregnancy losses? A systematic review of the literature and meta-analysis. Hum Reprod Update. 2020;26(3):356-367. https://doi.org/10.1093/humupd/dmz048</mixed-citation><mixed-citation xml:lang="en">van Dijk MM, Kolte AM, Limpens J, Kirk E, Quenby S, et al. Recurrent pregnancy loss: diagnostic workup after two or three pregnancy losses? A systematic review of the literature and meta-analysis. Hum Reprod Update. 2020;26(3):356-367. https://doi.org/10.1093/humupd/dmz048</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Magnus MC, Wilcox AJ, Morken NH, Weinberg CR, Håberg SE. Role of maternal age and pregnancy history in risk of miscarriage: prospective register based study. BMJ. 2019;364:l869. https://doi.org/10.1136/bmj.l869</mixed-citation><mixed-citation xml:lang="en">Magnus MC, Wilcox AJ, Morken NH, Weinberg CR, Håberg SE. Role of maternal age and pregnancy history in risk of miscarriage: prospective register based study. BMJ. 2019;364:l869. https://doi.org/10.1136/bmj.l869</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Rasmark Roepke E, Matthiesen L, Rylance R, Christiansen OB. Is the incidence of recurrent pregnancy loss increasing? A retrospective register-based study in Sweden. Acta Obstet Gynecol Scand. 2017;96(11):1365-1372. https://doi.org/10.1111/aogs.13210</mixed-citation><mixed-citation xml:lang="en">Rasmark Roepke E, Matthiesen L, Rylance R, Christiansen OB. Is the incidence of recurrent pregnancy loss increasing? A retrospective register-based study in Sweden. Acta Obstet Gynecol Scand. 2017;96(11):1365-1372. https://doi.org/10.1111/aogs.13210</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Quenby S, Gallos ID, Dhillon-Smith RK, Podesek M, Stephenson MD, et al. Miscarriage matters: the epidemiological, physical, psychological, and economic costs of early pregnancy loss. Lancet. 2021;397(10285):1658-1667. https://doi.org/10.1016/S0140-6736(21)00682-6</mixed-citation><mixed-citation xml:lang="en">Quenby S, Gallos ID, Dhillon-Smith RK, Podesek M, Stephenson MD, et al. Miscarriage matters: the epidemiological, physical, psychological, and economic costs of early pregnancy loss. Lancet. 2021;397(10285):1658-1667. https://doi.org/10.1016/S0140-6736(21)00682-6</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Lund M, Kamper-Jørgensen M, Nielsen HS, Lidegaard Ø, Andersen AM, Christiansen OB. Prognosis for live birth in women with recurrent miscarriage: what is the best measure of success? Obstet Gynecol. 2012;119(1):37-43. https://doi.org/10.1097/AOG.0b013e31823c0413</mixed-citation><mixed-citation xml:lang="en">Lund M, Kamper-Jørgensen M, Nielsen HS, Lidegaard Ø, Andersen AM, Christiansen OB. Prognosis for live birth in women with recurrent miscarriage: what is the best measure of success? Obstet Gynecol. 2012;119(1):37-43. https://doi.org/10.1097/AOG.0b013e31823c0413</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Nybo Andersen AM, Wohlfahrt J, Christens P, Olsen J, Melbye M. Maternal age and fetal loss: population based register linkage study. BMJ. 2000;320(7251):1708-1712. https://doi.org/10.1136/bmj.320.7251.1708</mixed-citation><mixed-citation xml:lang="en">Nybo Andersen AM, Wohlfahrt J, Christens P, Olsen J, Melbye M. Maternal age and fetal loss: population based register linkage study. BMJ. 2000;320(7251):1708-1712. https://doi.org/10.1136/bmj.320.7251.1708</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">van den Boogaard E, Cohn DM, Korevaar JC, Dawood F, Vissenberg R, et al. Number and sequence of preceding miscarriages and maternal age for the prediction of antiphospholipid syndrome in women with recurrent miscarriage. Fertil Steril. 2013;99(1):188-192. https://doi.org/10.1016/j.fertnstert.2012.09.002</mixed-citation><mixed-citation xml:lang="en">van den Boogaard E, Cohn DM, Korevaar JC, Dawood F, Vissenberg R, et al. Number and sequence of preceding miscarriages and maternal age for the prediction of antiphospholipid syndrome in women with recurrent miscarriage. Fertil Steril. 2013;99(1):188-192. https://doi.org/10.1016/j.fertnstert.2012.09.002</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Dimitriadis E, Menkhorst E, Saito S, Kutteh WH, Brosens JJ. Recurrent pregnancy loss. Nat Rev Dis Primers. 2020;6(1):98. https://doi.org/10.1038/s41572-020-00228-z</mixed-citation><mixed-citation xml:lang="en">Dimitriadis E, Menkhorst E, Saito S, Kutteh WH, Brosens JJ. Recurrent pregnancy loss. Nat Rev Dis Primers. 2020;6(1):98. https://doi.org/10.1038/s41572-020-00228-z</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Leng T, Li X, Zhang H. Levothyroxine treatment for subclinical hypothyroidism improves the rate of live births in pregnant women with recurrent pregnancy loss: a randomized clinical trial. Gynecol Endocrinol. 2022;38(6):488-494. https://doi.org/10.1080/09513590.2022.2063831</mixed-citation><mixed-citation xml:lang="en">Leng T, Li X, Zhang H. Levothyroxine treatment for subclinical hypothyroidism improves the rate of live births in pregnant women with recurrent pregnancy loss: a randomized clinical trial. Gynecol Endocrinol. 2022;38(6):488-494. https://doi.org/10.1080/09513590.2022.2063831</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">van Dijk MM, Vissenberg R, Fliers E, van der Post JAM, van der Hoorn MP, et al. Levothyroxine in euthyroid thyroid peroxidase antibody positive women with recurrent pregnancy loss (T4LIFE trial): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Diabetes Endocrinol. 2022;10(5):322-329. https://doi.org/10.1016/S2213-8587(22)00045-6</mixed-citation><mixed-citation xml:lang="en">van Dijk MM, Vissenberg R, Fliers E, van der Post JAM, van der Hoorn MP, et al. Levothyroxine in euthyroid thyroid peroxidase antibody positive women with recurrent pregnancy loss (T4LIFE trial): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Diabetes Endocrinol. 2022;10(5):322-329. https://doi.org/10.1016/S2213-8587(22)00045-6</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Tise CG, Byers HM. Genetics of recurrent pregnancy loss: a review. Curr Opin Obstet Gynecol. 2021;33(2):106-111. https://doi.org/10.1097/GCO.0000000000000695</mixed-citation><mixed-citation xml:lang="en">Tise CG, Byers HM. Genetics of recurrent pregnancy loss: a review. Curr Opin Obstet Gynecol. 2021;33(2):106-111. https://doi.org/10.1097/GCO.0000000000000695</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Smits MAJ, van Maarle M, Hamer G, Mastenbroek S, Goddijn M, van Wely M. Cytogenetic testing of pregnancy loss tissue: a meta-analysis. Reprod Biomed Online. 2020;40(6):867-879. https://doi.org/10.1016/j.rbmo.2020.02.001</mixed-citation><mixed-citation xml:lang="en">Smits MAJ, van Maarle M, Hamer G, Mastenbroek S, Goddijn M, van Wely M. Cytogenetic testing of pregnancy loss tissue: a meta-analysis. Reprod Biomed Online. 2020;40(6):867-879. https://doi.org/10.1016/j.rbmo.2020.02.001</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Maddirevula S, Awartani K, Coskun S, AlNaim LF, Ibrahim N, et al. A genomics approach to females with infertility and recurrent pregnancy loss. Hum Genet. 2020;139(5):605-613. https://doi.org/10.1007/s00439-020-02143-5</mixed-citation><mixed-citation xml:lang="en">Maddirevula S, Awartani K, Coskun S, AlNaim LF, Ibrahim N, et al. A genomics approach to females with infertility and recurrent pregnancy loss. Hum Genet. 2020;139(5):605-613. https://doi.org/10.1007/s00439-020-02143-5</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Li S, Zheng PS, Ma HM, Feng Q, Zhang YR, et al. Systematic review of subsequent pregnancy outcomes in couples with parental abnormal chromosomal karyotypes and recurrent pregnancy loss. Fertil Steril. 2022;118(5):906-914. https://doi.org/10.1016/j.fertnstert.2022.08.008</mixed-citation><mixed-citation xml:lang="en">Li S, Zheng PS, Ma HM, Feng Q, Zhang YR, et al. Systematic review of subsequent pregnancy outcomes in couples with parental abnormal chromosomal karyotypes and recurrent pregnancy loss. Fertil Steril. 2022;118(5):906-914. https://doi.org/10.1016/j.fertnstert.2022.08.008</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Deshmukh H, Way SS. Immunological Basis for Recurrent Fetal Loss and Pregnancy Complications. Annu Rev Pathol. 2019;14:185-210. https://doi.org/10.1146/annurev-pathmechdis-012418-012743</mixed-citation><mixed-citation xml:lang="en">Deshmukh H, Way SS. Immunological Basis for Recurrent Fetal Loss and Pregnancy Complications. Annu Rev Pathol. 2019;14:185-210. https://doi.org/10.1146/annurev-pathmechdis-012418-012743</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Gleicher N, Kushnir VA, Barad DH. Redirecting reproductive immunology research toward pregnancy as a period of temporary immune tolerance. J Assist Reprod Genet. 2017;34(4):425-430. https://doi.org/10.1007/s10815-017-0874-x</mixed-citation><mixed-citation xml:lang="en">Gleicher N, Kushnir VA, Barad DH. Redirecting reproductive immunology research toward pregnancy as a period of temporary immune tolerance. J Assist Reprod Genet. 2017;34(4):425-430. https://doi.org/10.1007/s10815-017-0874-x</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Ticconi C, Pietropolli A, Di Simone N, Piccione E, Fazleabas A. Endometrial Immune Dysfunction in Recurrent Pregnancy Loss. Int J Mol Sci. 2019;20(21):5332. https://doi.org/10.3390/ijms20215332</mixed-citation><mixed-citation xml:lang="en">Ticconi C, Pietropolli A, Di Simone N, Piccione E, Fazleabas A. Endometrial Immune Dysfunction in Recurrent Pregnancy Loss. Int J Mol Sci. 2019;20(21):5332. https://doi.org/10.3390/ijms20215332</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Wang W, Sung N, Gilman-Sachs A, Kwak-Kim J. T Helper (Th) Cell Profiles in Pregnancy and Recurrent Pregnancy Losses: Th1/Th2/Th9/Th17/Th22/Tfh Cells. Front Immunol. 2020;11:2025. https://doi.org/10.3389/fimmu.2020.02025</mixed-citation><mixed-citation xml:lang="en">Wang W, Sung N, Gilman-Sachs A, Kwak-Kim J. T Helper (Th) Cell Profiles in Pregnancy and Recurrent Pregnancy Losses: Th1/Th2/Th9/Th17/Th22/Tfh Cells. Front Immunol. 2020;11:2025. https://doi.org/10.3389/fimmu.2020.02025</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Jeve YB, Davies W. Evidence-based management of recurrent miscarriages. J Hum Reprod Sci. 2014;7(3):159-169. https://doi.org/10.4103/0974-1208.142475</mixed-citation><mixed-citation xml:lang="en">Jeve YB, Davies W. Evidence-based management of recurrent miscarriages. J Hum Reprod Sci. 2014;7(3):159-169. https://doi.org/10.4103/0974-1208.142475</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Wang NF, Kolte AM, Larsen EC, Nielsen HS, Christiansen OB. Immunologic Abnormalities, Treatments, and Recurrent Pregnancy Loss: What Is Real and What Is Not? Clin Obstet Gynecol. 2016;59(3):509-523. https://doi.org/10.1097/GRF.0000000000000215</mixed-citation><mixed-citation xml:lang="en">Wang NF, Kolte AM, Larsen EC, Nielsen HS, Christiansen OB. Immunologic Abnormalities, Treatments, and Recurrent Pregnancy Loss: What Is Real and What Is Not? Clin Obstet Gynecol. 2016;59(3):509-523. https://doi.org/10.1097/GRF.0000000000000215</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Ewington LJ, Tewary S, Brosens JJ. New insights into the mechanisms underlying recurrent pregnancy loss. J Obstet Gynaecol Res. 2019;45(2):258-265. https://doi.org/10.1111/jog.13837</mixed-citation><mixed-citation xml:lang="en">Ewington LJ, Tewary S, Brosens JJ. New insights into the mechanisms underlying recurrent pregnancy loss. J Obstet Gynaecol Res. 2019;45(2):258-265. https://doi.org/10.1111/jog.13837</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Makieva S, Giacomini E, Ottolina J, Sanchez AM, Papaleo E, Viganò P. Inside the Endometrial Cell Signaling Subway: Mind the Gap(s). Int J Mol Sci. 2018;19(9):2477. https://doi.org/10.3390/ijms19092477</mixed-citation><mixed-citation xml:lang="en">Makieva S, Giacomini E, Ottolina J, Sanchez AM, Papaleo E, Viganò P. Inside the Endometrial Cell Signaling Subway: Mind the Gap(s). Int J Mol Sci. 2018;19(9):2477. https://doi.org/10.3390/ijms19092477</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Chen P, Zhou L, Chen J, Lu Y, Cao C, et al. The Immune Atlas of Human Deciduas With Unexplained Recurrent Pregnancy Loss. Front Immunol. 2021;12:689019. https://doi.org/10.3389/fimmu.2021.689019</mixed-citation><mixed-citation xml:lang="en">Chen P, Zhou L, Chen J, Lu Y, Cao C, et al. The Immune Atlas of Human Deciduas With Unexplained Recurrent Pregnancy Loss. Front Immunol. 2021;12:689019. https://doi.org/10.3389/fimmu.2021.689019</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Dosiou C, Giudice LC. Natural killer cells in pregnancy and recurrent pregnancy loss: endocrine and immunologic perspectives. Endocr Rev. 2005;26(1):44-62. https://doi.org/10.1210/er.2003-0021</mixed-citation><mixed-citation xml:lang="en">Dosiou C, Giudice LC. Natural killer cells in pregnancy and recurrent pregnancy loss: endocrine and immunologic perspectives. Endocr Rev. 2005;26(1):44-62. https://doi.org/10.1210/er.2003-0021</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Tang AW, Alfirevic Z, Turner MA, Drury JA, Small R, Quenby S. A feasibility trial of screening women with idiopathic recurrent miscarriage for high uterine natural killer cell density and randomizing to prednisolone or placebo when pregnant. Hum Reprod. 2013;28(7):1743-1752. https://doi.org/10.1093/humrep/det117</mixed-citation><mixed-citation xml:lang="en">Tang AW, Alfirevic Z, Turner MA, Drury JA, Small R, Quenby S. A feasibility trial of screening women with idiopathic recurrent miscarriage for high uterine natural killer cell density and randomizing to prednisolone or placebo when pregnant. Hum Reprod. 2013;28(7):1743-1752. https://doi.org/10.1093/humrep/det117</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Kuon RJ, Weber M, Heger J, Santillán I, Vomstein K, et al. Uterine natural killer cells in patients with idiopathic recurrent miscarriage. Am J Reprod Immunol. 2017;78(4). https://doi.org/10.1111/aji.12721</mixed-citation><mixed-citation xml:lang="en">Kuon RJ, Weber M, Heger J, Santillán I, Vomstein K, et al. Uterine natural killer cells in patients with idiopathic recurrent miscarriage. Am J Reprod Immunol. 2017;78(4). https://doi.org/10.1111/aji.12721</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">El-Azzamy H, Dambaeva SV, Katukurundage D, Salazar Garcia MD, Skariah A, et al. Dysregulated uterine natural killer cells and vascular remodeling in women with recurrent pregnancy losses. Am J Reprod Immunol. 2018;80(4):e13024. https://doi.org/10.1111/aji.13024</mixed-citation><mixed-citation xml:lang="en">El-Azzamy H, Dambaeva SV, Katukurundage D, Salazar Garcia MD, Skariah A, et al. Dysregulated uterine natural killer cells and vascular remodeling in women with recurrent pregnancy losses. Am J Reprod Immunol. 2018;80(4):e13024. https://doi.org/10.1111/aji.13024</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Gong H, Chen Y, Xu J, Xie X, Yu D, et al. The regulation of ovary and conceptus on the uterine natural killer cells during early pregnancy. Reprod Biol Endocrinol. 2017;15(1):73. https://doi.org/10.1186/s12958-017-0290-1</mixed-citation><mixed-citation xml:lang="en">Gong H, Chen Y, Xu J, Xie X, Yu D, et al. The regulation of ovary and conceptus on the uterine natural killer cells during early pregnancy. Reprod Biol Endocrinol. 2017;15(1):73. https://doi.org/10.1186/s12958-017-0290-1</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Giuliani E, Parkin KL, Lessey BA, Young SL, Fazleabas AT. Characterization of uterine NK cells in women with infertility or recurrent pregnancy loss and associated endometriosis. Am J Reprod Immunol. 2014;72(3):262-269. https://doi.org/10.1111/aji.12259</mixed-citation><mixed-citation xml:lang="en">Giuliani E, Parkin KL, Lessey BA, Young SL, Fazleabas AT. Characterization of uterine NK cells in women with infertility or recurrent pregnancy loss and associated endometriosis. Am J Reprod Immunol. 2014;72(3):262-269. https://doi.org/10.1111/aji.12259</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Wang W, Zhao Y, Zhou X, Sung N, Chen L, et al. Dynamic changes in regulatory T cells during normal pregnancy, recurrent pregnancy loss, and gestational diabetes. J Reprod Immunol. 2022;150:103492. https://doi.org/10.1016/j.jri.2022.103492</mixed-citation><mixed-citation xml:lang="en">Wang W, Zhao Y, Zhou X, Sung N, Chen L, et al. Dynamic changes in regulatory T cells during normal pregnancy, recurrent pregnancy loss, and gestational diabetes. J Reprod Immunol. 2022;150:103492. https://doi.org/10.1016/j.jri.2022.103492</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Mor G, Aldo P, Alvero AB. The unique immunological and microbial aspects of pregnancy. Nat Rev Immunol. 2017;17(8):469-482. https://doi.org/10.1038/nri.2017.64</mixed-citation><mixed-citation xml:lang="en">Mor G, Aldo P, Alvero AB. The unique immunological and microbial aspects of pregnancy. Nat Rev Immunol. 2017;17(8):469-482. https://doi.org/10.1038/nri.2017.64</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Ticconi C, Pietropolli A, Di Simone N, Piccione E, Fazleabas A. Endometrial Immune Dysfunction in Recurrent Pregnancy Loss. Int J Mol Sci. 2019;20(21):5332. https://doi.org/10.3390/ijms20215332</mixed-citation><mixed-citation xml:lang="en">Ticconi C, Pietropolli A, Di Simone N, Piccione E, Fazleabas A. Endometrial Immune Dysfunction in Recurrent Pregnancy Loss. Int J Mol Sci. 2019;20(21):5332. https://doi.org/10.3390/ijms20215332</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Gellersen B, Brosens JJ. Cyclic decidualization of the human endometrium in reproductive health and failure. Endocr Rev. 2014;35(6):851-905. https://doi.org/10.1210/er.2014-1045</mixed-citation><mixed-citation xml:lang="en">Gellersen B, Brosens JJ. Cyclic decidualization of the human endometrium in reproductive health and failure. Endocr Rev. 2014;35(6):851-905. https://doi.org/10.1210/er.2014-1045</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Salker MS, Nautiyal J, Steel JH, Webster Z, Sućurović S, et al. Disordered IL-33/ST2 activation in decidualizing stromal cells prolongs uterine receptivity in women with recurrent pregnancy loss. PLoS One. 2012;7(12):e52252. https://doi.org/10.1371/journal.pone.0052252</mixed-citation><mixed-citation xml:lang="en">Salker MS, Nautiyal J, Steel JH, Webster Z, Sućurović S, et al. Disordered IL-33/ST2 activation in decidualizing stromal cells prolongs uterine receptivity in women with recurrent pregnancy loss. PLoS One. 2012;7(12):e52252. https://doi.org/10.1371/journal.pone.0052252</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">Macklon NS, Brosens JJ. The human endometrium as a sensor of embryo quality. Biol Reprod. 2014;91(4):98. https://doi.org/10.1095/biolreprod.114.122846</mixed-citation><mixed-citation xml:lang="en">Macklon NS, Brosens JJ. The human endometrium as a sensor of embryo quality. Biol Reprod. 2014;91(4):98. https://doi.org/10.1095/biolreprod.114.122846</mixed-citation></citation-alternatives></ref><ref id="cit41"><label>41</label><citation-alternatives><mixed-citation xml:lang="ru">Teklenburg G, Salker M, Molokhia M, Lavery S, Trew G, et al. Natural selection of human embryos: decidualizing endometrial stromal cells serve as sensors of embryo quality upon implantation. PLoS One. 2010;5(4):e10258. https://doi.org/10.1371/journal.pone.0010258</mixed-citation><mixed-citation xml:lang="en">Teklenburg G, Salker M, Molokhia M, Lavery S, Trew G, et al. Natural selection of human embryos: decidualizing endometrial stromal cells serve as sensors of embryo quality upon implantation. PLoS One. 2010;5(4):e10258. https://doi.org/10.1371/journal.pone.0010258</mixed-citation></citation-alternatives></ref><ref id="cit42"><label>42</label><citation-alternatives><mixed-citation xml:lang="ru">Lucas ES, Dyer NP, Murakami K, Lee YH, Chan YW, et al. Loss of Endometrial Plasticity in Recurrent Pregnancy Loss. Stem Cells. 2016;34(2):346-356. https://doi.org/10.1002/stem.2222</mixed-citation><mixed-citation xml:lang="en">Lucas ES, Dyer NP, Murakami K, Lee YH, Chan YW, et al. Loss of Endometrial Plasticity in Recurrent Pregnancy Loss. Stem Cells. 2016;34(2):346-356. https://doi.org/10.1002/stem.2222</mixed-citation></citation-alternatives></ref><ref id="cit43"><label>43</label><citation-alternatives><mixed-citation xml:lang="ru">Liu Y, Chen X, Huang J, Wang CC, Yu MY, et al. Comparison of the prevalence of chronic endometritis as determined by means of different diagnostic methods in women with and without reproductive failure. Fertil Steril. 2018;109(5):832-839. Erratum in: Fertil Steril. 2019;111(2):411. PMID: 29778382. https://doi.org/10.1016/j.fertnstert.2018.01.022</mixed-citation><mixed-citation xml:lang="en">Liu Y, Chen X, Huang J, Wang CC, Yu MY, et al. Comparison of the prevalence of chronic endometritis as determined by means of different diagnostic methods in women with and without reproductive failure. Fertil Steril. 2018;109(5):832-839. Erratum in: Fertil Steril. 2019;111(2):411. PMID: 29778382. https://doi.org/10.1016/j.fertnstert.2018.01.022</mixed-citation></citation-alternatives></ref><ref id="cit44"><label>44</label><citation-alternatives><mixed-citation xml:lang="ru">Лызикова Ю.А., Осипкина О.В., Зятьков А.А., Рубаник Н.Н. Результаты идентификации микроорганизмов в полости матки с помощью метода секвенирования фрагмента гена 16S РРНК. Проблемы здоровья и экологии. 2018;(4):24-30.</mixed-citation><mixed-citation xml:lang="en">Lyzikova Yu.A., Osipkina O.V., Zyatkov A.A., Rubanik N.N. The Results of Identification of Microorganisms from the Uterine Cavity by Means of the Method of 16s Rrna Gene Fragment Sequencing. Health and Ecology Issues. 2018;(4):24-30. (In Russ.) https://doi.org/10.51523/2708-6011.2018-15-4-5</mixed-citation></citation-alternatives></ref><ref id="cit45"><label>45</label><citation-alternatives><mixed-citation xml:lang="ru">Reschini M, Benaglia L, Ceriotti F, Borroni R, Ferrari S, et al. Endometrial microbiome: sampling, assessment, and possible impact on embryo implantation. Sci Rep. 2022;12(1):8467. https://doi.org/10.1038/s41598-022-12095-7</mixed-citation><mixed-citation xml:lang="en">Reschini M, Benaglia L, Ceriotti F, Borroni R, Ferrari S, et al. Endometrial microbiome: sampling, assessment, and possible impact on embryo implantation. Sci Rep. 2022;12(1):8467. https://doi.org/10.1038/s41598-022-12095-7</mixed-citation></citation-alternatives></ref><ref id="cit46"><label>46</label><citation-alternatives><mixed-citation xml:lang="ru">Moreno I, Codoñer FM, Vilella F, Valbuena D, Martinez-Blanch JF, et al. Evidence that the endometrial microbiota has an effect on implantation success or failure. Am J Obstet Gynecol. 2016;215(6):684-703. https://doi.org/10.1016/j.ajog.2016.09.075</mixed-citation><mixed-citation xml:lang="en">Moreno I, Codoñer FM, Vilella F, Valbuena D, MartinezBlanch JF, et al. Evidence that the endometrial microbiota has an effect on implantation success or failure. Am J Obstet Gynecol. 2016;215(6):684-703. https://doi.org/10.1016/j.ajog.2016.09.075</mixed-citation></citation-alternatives></ref><ref id="cit47"><label>47</label><citation-alternatives><mixed-citation xml:lang="ru">Червинец Ю.В., Червинец В.М., Стольникова И.И., Досова С.Ю. Особенности микробиоты влагалища при привычном невынашивании беременности. Тверской медицинский журнал. 2021;(2):33-43.</mixed-citation><mixed-citation xml:lang="en">Chervinets Yu.V., Chervinets V.M., Stolnikova I.I., Dosova S.Y. The features of vagina microbiota in women with habitual miscarriage. Tverskoi meditsinskii zhurnal. 2021;(2):33-43. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit48"><label>48</label><citation-alternatives><mixed-citation xml:lang="ru">Peuranpää P, Holster T, Saqib S, Kalliala I, Tiitinen A, et al. Female reproductive tract microbiota and recurrent pregnancy loss: a nested case-control study. Reprod Biomed Online. 2022;45(5):1021-1031. https://doi.org/10.1016/j.rbmo.2022.06.008</mixed-citation><mixed-citation xml:lang="en">Peuranpää P, Holster T, Saqib S, Kalliala I, Tiitinen A, et al. Female reproductive tract microbiota and recurrent pregnancy loss: a nested case-control study. Reprod Biomed Online. 2022;45(5):1021-1031. https://doi.org/10.1016/j.rbmo.2022.06.008</mixed-citation></citation-alternatives></ref><ref id="cit49"><label>49</label><citation-alternatives><mixed-citation xml:lang="ru">Ефремова Н.В., Румянцева З.С., Резниченко Н.А. Анализ микробиологических предикторов невынашивания беременности. Вопросы устойчивого развития общества. 2022;(3):838-842.</mixed-citation><mixed-citation xml:lang="en">Efremova N.V., Rumyantseva Z.S., Reznichenko N.A. Analysis of microbiological predictors of miscarriage. Voprosy ustoichivogo razvitiya obshchestva. 2022;(3):838-842. (In Russ.) eLIBRARY ID: 48251228 EDN: FJENXC</mixed-citation></citation-alternatives></ref><ref id="cit50"><label>50</label><citation-alternatives><mixed-citation xml:lang="ru">Shi Y, Yamada H, Sasagawa Y, Tanimura K, Deguchi M. Uterine endometrium microbiota and pregnancy outcome in women with recurrent pregnancy loss. J Reprod Immunol. 2022;152:103653. https://doi.org/10.1016/j.jri.2022.103653</mixed-citation><mixed-citation xml:lang="en">Shi Y, Yamada H, Sasagawa Y, Tanimura K, Deguchi M. Uterine endometrium microbiota and pregnancy outcome in women with recurrent pregnancy loss. J Reprod Immunol. 2022;152:103653. https://doi.org/10.1016/j.jri.2022.103653</mixed-citation></citation-alternatives></ref><ref id="cit51"><label>51</label><citation-alternatives><mixed-citation xml:lang="ru">Salama SA, Kamel MW, Diaz-Arrastia CR, Xu X, Veenstra TD, et al. Effect of tumor necrosis factor-alpha on estrogen metabolism and endometrial cells: potential physiological and pathological relevance. J Clin Endocrinol Metab. 2009;94(1):285-293. https://doi.org/10.1210/jc.2008-1389</mixed-citation><mixed-citation xml:lang="en">Salama SA, Kamel MW, Diaz-Arrastia CR, Xu X, Veenstra TD, et al. Effect of tumor necrosis factor-alpha on estrogen metabolism and endometrial cells: potential physiological and pathological relevance. J Clin Endocrinol Metab. 2009;94(1):285-293. https://doi.org/10.1210/jc.2008-1389</mixed-citation></citation-alternatives></ref><ref id="cit52"><label>52</label><citation-alternatives><mixed-citation xml:lang="ru">Cicinelli E, Resta L, Nicoletti R, Zappimbulso V, Tartagni M, Saliani N. Endometrial micropolyps at fluid hysteroscopy suggest the existence of chronic endometritis. Hum Reprod. 2005;20(5):1386-1389. https://doi.org/10.1093/humrep/deh779</mixed-citation><mixed-citation xml:lang="en">Cicinelli E, Resta L, Nicoletti R, Zappimbulso V, Tartagni M, Saliani N. Endometrial micropolyps at fluid hysteroscopy suggest the existence of chronic endometritis. Hum Reprod. 2005;20(5):1386-1389. https://doi.org/10.1093/humrep/deh779</mixed-citation></citation-alternatives></ref><ref id="cit53"><label>53</label><citation-alternatives><mixed-citation xml:lang="ru">Траль Т.Г., Хобец В.В., Толибова Г.Х., Коган И.Ю. Структурно-функциональные и молекулярные механизмы трансформации эндометрия при привычном невынашивании беременности. Уральский медицинский журнал. 2022;21(5):18-25.</mixed-citation><mixed-citation xml:lang="en">Tral T.G., Khobets V.V., Tolibova G.Kh., Kogan I.Yu. Structural, functional, and molecular mechanisms of endometrial transformation in habitual pregnancy failure. Ural Medical Journal. 2022;21(5):18-25. (In Russ.) https://doi.org/10.52420/2071-5943-2022-21-5-18-25</mixed-citation></citation-alternatives></ref><ref id="cit54"><label>54</label><citation-alternatives><mixed-citation xml:lang="ru">Общероссийская общественная организация Ассоциация ревматологов России. Федеральные клинические рекомендации по лечению антифосфолипидного синдрома. М.: 2013.</mixed-citation><mixed-citation xml:lang="en">Russian public organization «Association of Rheumatologists of Russia». Federal clinical guidelines for the treatment of antiphospholipid syndrome. Мoscow; 2013.</mixed-citation></citation-alternatives></ref><ref id="cit55"><label>55</label><citation-alternatives><mixed-citation xml:lang="ru">Russian public organization «Association of Rheumatologists of Russia». Federal clinical guidelines for the treatment of antiphospholipid syndrome. Мoscow; 2013.</mixed-citation><mixed-citation xml:lang="en">Alijotas-Reig J, Esteve-Valverde E, Anunciación-Llunell A, Marques-Soares J, Pardos-Gea J, Miró-Mur F. Pathogenesis, Diagnosis and Management of Obstetric Antiphospholipid Syndrome: A Comprehensive Review. J Clin Med. 2022;11(3):675. https://doi.org/10.3390/jcm11030675</mixed-citation></citation-alternatives></ref><ref id="cit56"><label>56</label><citation-alternatives><mixed-citation xml:lang="ru">Alijotas-Reig J, Esteve-Valverde E, Anunciación-Llunell A, Marques-Soares J, Pardos-Gea J, Miró-Mur F. Pathogenesis, Diagnosis and Management of Obstetric Antiphospholipid Syndrome: A Comprehensive Review. J Clin Med. 2022;11(3):675. https://doi.org/10.3390/jcm11030675</mixed-citation><mixed-citation xml:lang="en">Sjöberg V, Sandström O, Hedberg M, Hammarström S, Hernell O, Hammarström ML. Intestinal T-cell responses in celiac disease – impact of celiac disease associated bacteria. PLoS One. 2013;8(1):e53414. https://doi.org/10.1371/journal.pone.0053414</mixed-citation></citation-alternatives></ref><ref id="cit57"><label>57</label><citation-alternatives><mixed-citation xml:lang="ru">Sjöberg V, Sandström O, Hedberg M, Hammarström S, Hernell O, Hammarström ML. Intestinal T-cell responses in celiac disease – impact of celiac disease associated bacteria. PLoS One. 2013;8(1):e53414. https://doi.org/10.1371/journal.pone.0053414</mixed-citation><mixed-citation xml:lang="en">Toth B, Würfel W, Bohlmann M, Zschocke J, RudnikSchöneborn S, et al. Recurrent Miscarriage: Diagnostic and Therapeutic Procedures. Guideline of the DGGG, OEGGG and SGGG (S2k-Level, AWMF Registry Number 015/050). Geburtshilfe Frauenheilkd. 2018;78(4):364-381. https://doi.org/10.1055/a-0586-4568</mixed-citation></citation-alternatives></ref><ref id="cit58"><label>58</label><citation-alternatives><mixed-citation xml:lang="ru">Toth B, Würfel W, Bohlmann M, Zschocke J, Rudnik-Schöneborn S, et al. Recurrent Miscarriage: Diagnostic and Therapeutic Procedures. Guideline of the DGGG, OEGGG and SGGG (S2k-Level, AWMF Registry Number 015/050). Geburtshilfe Frauenheilkd. 2018;78(4):364-381. https://doi.org/10.1055/a-0586-4568</mixed-citation><mixed-citation xml:lang="en">Masucci L, D'Ippolito S, De Maio F, Quaranta G, Mazzarella R, et al. Celiac Disease Predisposition and Genital Tract Microbiota in Women Affected by Recurrent Pregnancy Loss. Nutrients. 2023;15(1):221. https://doi.org/10.3390/nu15010221</mixed-citation></citation-alternatives></ref><ref id="cit59"><label>59</label><citation-alternatives><mixed-citation xml:lang="ru">Masucci L, D'Ippolito S, De Maio F, Quaranta G, Mazzarella R, et al. Celiac Disease Predisposition and Genital Tract Microbiota in Women Affected by Recurrent Pregnancy Loss. Nutrients. 2023;15(1):221. https://doi.org/10.3390/nu15010221</mixed-citation><mixed-citation xml:lang="en">Mierendorf SM, Shmerling RH. Antinuclear antibody testing. Hospital Med Clin. 2012;1(3):e370-e377. https://doi.org/10.1016/j.ehmc.2011.11.001</mixed-citation></citation-alternatives></ref><ref id="cit60"><label>60</label><citation-alternatives><mixed-citation xml:lang="ru">Mierendorf SM, Shmerling RH. Antinuclear antibody testing. Hospital Med Clin. 2012;1(3):e370-e377. https://doi.org/10.1016/j.ehmc.2011.11.001</mixed-citation><mixed-citation xml:lang="en">Chen S, Yang G, Wu P, Sun Y, Dai F, et al. Antinuclear antibodies positivity is a risk factor of recurrent pregnancy loss: A meta-analysis. Semin Arthritis Rheum. 2020;50(4):534-543. https://doi.org/10.1016/j.semarthrit.2020.03.016</mixed-citation></citation-alternatives></ref><ref id="cit61"><label>61</label><citation-alternatives><mixed-citation xml:lang="ru">Chen S, Yang G, Wu P, Sun Y, Dai F, et al. Antinuclear antibodies positivity is a risk factor of recurrent pregnancy loss: A meta-analysis. Semin Arthritis Rheum. 2020;50(4):534-543. https://doi.org/10.1016/j.semarthrit.2020.03.016</mixed-citation><mixed-citation xml:lang="en">Cavalcante MB, Cavalcante CTMB, Sarno M, da Silva ACB, Barini R. Antinuclear antibodies and recurrent miscarriage: Systematic review and meta-analysis. Am J Reprod Immunol. 2020;83(3):e13215. https://doi.org/10.1111/aji.13215</mixed-citation></citation-alternatives></ref><ref id="cit62"><label>62</label><citation-alternatives><mixed-citation xml:lang="ru">Cavalcante MB, Cavalcante CTMB, Sarno M, da Silva ACB, Barini R. Antinuclear antibodies and recurrent miscarriage: Systematic review and meta-analysis. Am J Reprod Immunol. 2020;83(3):e13215. https://doi.org/10.1111/aji.13215</mixed-citation><mixed-citation xml:lang="en">Yu W, Bao S. Association of male factors with recurrent pregnancy loss. J Reprod Immunol. 2022;154:103758. https://doi.org/10.1016/j.jri.2022.103758</mixed-citation></citation-alternatives></ref><ref id="cit63"><label>63</label><citation-alternatives><mixed-citation xml:lang="ru">Yu W, Bao S. Association of male factors with recurrent pregnancy loss. J Reprod Immunol. 2022;154:103758. https://doi.org/10.1016/j.jri.2022.103758</mixed-citation><mixed-citation xml:lang="en">Klimczak AM, Patel DP, Hotaling JM, Scott RT Jr. Role of the sperm, oocyte, and embryo in recurrent pregnancy loss. Fertil Steril. 2021;115(3):533-537. https://doi.org/10.1016/j.fertnstert.2020.12.005</mixed-citation></citation-alternatives></ref><ref id="cit64"><label>64</label><citation-alternatives><mixed-citation xml:lang="ru">Klimczak AM, Patel DP, Hotaling JM, Scott RT Jr. Role of the sperm, oocyte, and embryo in recurrent pregnancy loss. Fertil Steril. 2021;115(3):533-537. https://doi.org/10.1016/j.fertnstert.2020.12.005</mixed-citation><mixed-citation xml:lang="en">Lepine S, McDowell S, Searle LM, Kroon B, Glujovsky D, Yazdani A. Advanced sperm selection techniques for assisted reproduction. Cochrane Database Syst Rev. 2019;7(7):CD010461. https://doi.org/10.1002/14651858.CD010461.pub3</mixed-citation></citation-alternatives></ref><ref id="cit65"><label>65</label><citation-alternatives><mixed-citation xml:lang="ru">Lepine S, McDowell S, Searle LM, Kroon B, Glujovsky D, Yazdani A. Advanced sperm selection techniques for assisted reproduction. Cochrane Database Syst Rev. 2019;7(7):CD010461. https://doi.org/10.1002/14651858.CD010461.pub3</mixed-citation><mixed-citation xml:lang="en">du Fossé NA, Lashley EELO, van Beelen E, Meuleman T, le Cessie S, et al. Identification of distinct seminal plasma cytokine profiles associated with male age and lifestyle characteristics in unexplained recurrent pregnancy loss. J Reprod Immunol. 2021;147:103349. https://doi.org/10.1016/j.jri.2021.103349</mixed-citation></citation-alternatives></ref><ref id="cit66"><label>66</label><citation-alternatives><mixed-citation xml:lang="ru">du Fossé NA, Lashley EELO, van Beelen E, Meuleman T, le Cessie S, et al. Identification of distinct seminal plasma cytokine profiles associated with male age and lifestyle characteristics in unexplained recurrent pregnancy loss. J Reprod Immunol. 2021;147:103349. https://doi.org/10.1016/j.jri.2021.103349</mixed-citation><mixed-citation xml:lang="en">Mohanty G, Jena SR, Nayak J, Kar S, Samanta L. Quantitative proteomics decodes clusterin as a critical regulator of paternal factors responsible for impaired compensatory metabolic reprogramming in recurrent pregnancy loss. Andrologia. 2020;52(2):e13498. https://doi.org/10.1111/and.13498</mixed-citation></citation-alternatives></ref><ref id="cit67"><label>67</label><citation-alternatives><mixed-citation xml:lang="ru">Mohanty G, Jena SR, Nayak J, Kar S, Samanta L. Quantitative proteomics decodes clusterin as a critical regulator of paternal factors responsible for impaired compensatory metabolic reprogramming in recurrent pregnancy loss. Andrologia. 2020;52(2):e13498. https://doi.org/10.1111/and.13498</mixed-citation><mixed-citation xml:lang="en">Gamidov S.I., Shatylko T.V., Popova A.Yu., Gasanov N.G., Gamidov R.S. Sperm oxidative stress: clinical significance and management. Meditsinskiy sovet = Medical Council. 2021;(3):19-27. (In Russ.) https://doi.org/10.21518/2079-701X-2021-3-19-27</mixed-citation></citation-alternatives></ref><ref id="cit68"><label>68</label><citation-alternatives><mixed-citation xml:lang="ru">Гамидов С.И., Шатылко Т.В., Попова А.Ю., Гасанов Н.Г., Гамидов Р.С. Оксидативный стресс сперматозоидов: клиническое значение и коррекция. Медицинский Совет. 2021;(3):19-27.</mixed-citation><mixed-citation xml:lang="en">Al-Sheikh YA, Ghneim HK, Alharbi AF, Alshebly MM, Aljaser FS, Aboul-Soud MAM. Molecular and biochemical investigations of key antioxidant/oxidant molecules in Saudi patients with recurrent miscarriage. Exp Ther Med. 2019;18(6):4450-4460. https://doi.org/10.3892/etm.2019.8082</mixed-citation></citation-alternatives></ref><ref id="cit69"><label>69</label><citation-alternatives><mixed-citation xml:lang="ru">Al-Sheikh YA, Ghneim HK, Alharbi AF, Alshebly MM, Aljaser FS, Aboul-Soud MAM. Molecular and biochemical investigations of key antioxidant/oxidant molecules in Saudi patients with recurrent miscarriage. Exp Ther Med. 2019;18(6):4450-4460. https://doi.org/10.3892/etm.2019.8082</mixed-citation><mixed-citation xml:lang="en">Zussman R, Xu LY, Damani T, Groom KM, Chen Q, et al. Antiphospholipid antibodies can specifically target placental mitochondria and induce ROS production. J Autoimmun. 2020;111:102437. https://doi.org/10.1016/j.jaut.2020.102437</mixed-citation></citation-alternatives></ref><ref id="cit70"><label>70</label><citation-alternatives><mixed-citation xml:lang="ru">Zussman R, Xu LY, Damani T, Groom KM, Chen Q, et al. Antiphospholipid antibodies can specifically target placental mitochondria and induce ROS production. J Autoimmun. 2020;111:102437. https://doi.org/10.1016/j.jaut.2020.102437</mixed-citation><mixed-citation xml:lang="en">Nocella C, Bartimoccia S, Cammisotto V, D'Amico A, Pastori D, et al. Oxidative Stress in the Pathogenesis of Antiphospholipid Syndrome: Implications for the Atherothrombotic Process. Antioxidants (Basel). 2021;10(11):1790. https://doi.org/10.3390/antiox10111790</mixed-citation></citation-alternatives></ref><ref id="cit71"><label>71</label><citation-alternatives><mixed-citation xml:lang="ru">Nocella C, Bartimoccia S, Cammisotto V, D'Amico A, Pastori D, et al. Oxidative Stress in the Pathogenesis of Antiphospholipid Syndrome: Implications for the Atherothrombotic Process. Antioxidants (Basel). 2021;10(11):1790. https://doi.org/10.3390/antiox10111790</mixed-citation><mixed-citation xml:lang="en">Nocella C, Bartimoccia S, Cammisotto V, D'Amico A, Pastori D, et al. Oxidative Stress in the Pathogenesis of Antiphospholipid Syndrome: Implications for the Atherothrombotic Process. Antioxidants (Basel). 2021;10(11):1790. https://doi.org/10.3390/antiox10111790</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
